X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs CADILA HEALTHCARE - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES CADILA HEALTHCARE PIRAMAL ENTERPRISES/
CADILA HEALTHCARE
 
P/E (TTM) x 37.6 35.2 107.0% View Chart
P/BV x 3.7 9.1 41.4% View Chart
Dividend Yield % 0.6 0.7 96.0%  

Financials

 PIRAMAL ENTERPRISES   CADILA HEALTHCARE
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
CADILA HEALTHCARE
Mar-16
PIRAMAL ENTERPRISES/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,065454 234.4%   
Low Rs805305 264.4%   
Sales per share (Unadj.) Rs383.096.1 398.6%  
Earnings per share (Unadj.) Rs55.114.9 370.4%  
Cash flow per share (Unadj.) Rs74.117.8 415.5%  
Dividends per share (Unadj.) Rs17.503.20 546.9%  
Dividend yield (eoy) %1.90.8 221.9%  
Book value per share (Unadj.) Rs719.952.3 1,377.0%  
Shares outstanding (eoy) m172.561,023.74 16.9%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x2.43.9 61.8%   
Avg P/E ratio x17.025.5 66.5%  
P/CF ratio (eoy) x12.621.3 59.3%  
Price / Book Value ratio x1.37.3 17.9%  
Dividend payout %31.821.5 147.6%   
Avg Mkt Cap Rs m161,344388,458 41.5%   
No. of employees `0003.815.4 24.5%   
Total wages/salary Rs m16,89813,317 126.9%   
Avg. sales/employee Rs Th17,472.66,371.1 274.2%   
Avg. wages/employee Rs Th4,466.9862.4 517.9%   
Avg. net profit/employee Rs Th2,512.8986.1 254.8%   
INCOME DATA
Net Sales Rs m66,09998,376 67.2%  
Other income Rs m2,425941 257.7%   
Total revenues Rs m68,52499,317 69.0%   
Gross profit Rs m18,72323,829 78.6%  
Depreciation Rs m3,2743,022 108.4%   
Interest Rs m9,388486 1,931.6%   
Profit before tax Rs m8,48521,262 39.9%   
Minority Interest Rs m3-300 -1.1%   
Prior Period Items Rs m1,5935 31,856.0%   
Extraordinary Inc (Exp) Rs m457-25 -1,826.8%   
Tax Rs m1,0325,716 18.1%   
Profit after tax Rs m9,50615,226 62.4%  
Gross profit margin %28.324.2 116.9%  
Effective tax rate %12.226.9 45.2%   
Net profit margin %14.415.5 92.9%  
BALANCE SHEET DATA
Current assets Rs m47,48844,376 107.0%   
Current liabilities Rs m104,36234,071 306.3%   
Net working cap to sales %-86.010.5 -821.4%  
Current ratio x0.51.3 34.9%  
Inventory Days Days4154 75.4%  
Debtors Days Days5162 82.0%  
Net fixed assets Rs m26,53247,896 55.4%   
Share capital Rs m3451,024 33.7%   
"Free" reserves Rs m114,02448,746 233.9%   
Net worth Rs m124,22153,519 232.1%   
Long term debt Rs m75,8128,964 845.7%   
Total assets Rs m308,356100,163 307.9%  
Interest coverage x1.944.7 4.3%   
Debt to equity ratio x0.60.2 364.4%  
Sales to assets ratio x0.21.0 21.8%   
Return on assets %6.115.7 39.1%  
Return on equity %7.728.4 26.9%  
Return on capital %10.034.3 29.0%  
Exports to sales %17.245.3 38.0%   
Imports to sales %6.65.9 111.3%   
Exports (fob) Rs m11,36244,537 25.5%   
Imports (cif) Rs m4,3645,838 74.8%   
Fx inflow Rs m14,43544,881 32.2%   
Fx outflow Rs m5,1839,069 57.1%   
Net fx Rs m9,25335,812 25.8%   
CASH FLOW
From Operations Rs m-67,77319,938 -339.9%  
From Investments Rs m-8,768-9,039 97.0%  
From Financial Activity Rs m76,199-9,527 -799.8%  
Net Cashflow Rs m-3421,372 -25.0%  

Share Holding

Indian Promoters % 52.9 74.8 70.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 8.3 48.2%  
FIIs % 26.6 5.9 450.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 11.0 150.0%  
Shareholders   93,274 44,069 211.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   PANACEA BIOTECH  DISHMAN PHARMA  J.B.CHEMICALS  NATCO PHARMA  BIOCON LTD  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 18, 2017 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - ALEMBIC LTD COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS